Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quantum Biopharma Ltd (QNTM)

Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,758
  • Shares Outstanding, K 1,919
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,900 K
  • EBIT $ -11 M
  • EBITDA $ -9 M
  • 60-Month Beta 0.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.29

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 85.95%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 0.00% on 12/20/24
  • IV Low 0.00% on 12/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,869
  • Open Int (30-Day) 1,865

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.80
  • Number of Estimates 1
  • High Estimate -0.80
  • Low Estimate -0.80
  • Prior Year -2.60
  • Growth Rate Est. (year over year) +69.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.70 +11.11%
on 12/20/24
6.89 -56.46%
on 11/25/24
-2.03 (-40.36%)
since 11/20/24
3-Month
2.70 +11.11%
on 12/20/24
8.86 -66.14%
on 10/21/24
-1.13 (-27.36%)
since 09/20/24
52-Week
2.70 +11.11%
on 12/20/24
70.85 -95.77%
on 02/21/24
-59.08 (-95.17%)
since 12/20/23

Most Recent Stories

More News
Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that it has closed a second tranche...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that after receiving approval from...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
How This $4 Stock is Taking on Wall Street's Big Banks with a $700 Million Lawsuit

Two of America’s Most Prestigious Law Firms Team Up to Go After Several of Wall Street’s Biggest Banks on Behalf of Quantum BioPharma (NASDAQ: QNTM)—and Are So Confident, They Are Fronting the Legal...

QNTM : 3.00 (-13.29%)
TD : 52.25 (+1.34%)
C : 69.19 (+1.13%)
BAC : 44.17 (+1.82%)
JPM : 237.60 (+1.99%)
Quantum Biopharma Announces Closing of First Tranche

TORONTO, ONTARIO / ACCESSWIRE / December 13, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that it has closed an initial...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

TORONTO, ON / ACCESSWIRE / December 10, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

TORONTO, ON / ACCESSWIRE / December 10, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on...

QNTM : 3.00 (-13.29%)
QNTM.CN : 4.2100 (-19.81%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)

Business Summary

Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Quantum BioPharma,...

See More

Key Turning Points

3rd Resistance Point 5.10
2nd Resistance Point 4.56
1st Resistance Point 3.78
Last Price 3.00
1st Support Level 2.46
2nd Support Level 1.92
3rd Support Level 1.14

See More

52-Week High 70.85
Fibonacci 61.8% 44.82
Fibonacci 50% 36.77
Fibonacci 38.2% 28.73
Last Price 3.00
52-Week Low 2.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar